The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biologic Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Biologic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biologic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Diabetes accounting for % of the Biologic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Humira segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Biologic Drugs include Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biologic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Market segment by Application can be divided into
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
The key market players for global Biologic Drugs market are listed below:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biologic Drugs, with price, sales, revenue and global market share of Biologic Drugs from 2019 to 2022.
Chapter 3, the Biologic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Biologic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologic Drugs.
Chapter 13, 14, and 15, to describe Biologic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Biologic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biologic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Diabetes accounting for % of the Biologic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Humira segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Biologic Drugs include Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biologic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Market segment by Application can be divided into
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
The key market players for global Biologic Drugs market are listed below:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biologic Drugs, with price, sales, revenue and global market share of Biologic Drugs from 2019 to 2022.
Chapter 3, the Biologic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Biologic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologic Drugs.
Chapter 13, 14, and 15, to describe Biologic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Biologic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biologic Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Humira
1.2.3 Remicade
1.2.4 Rituxan
1.2.5 Enbrel
1.2.6 Lantus
1.2.7 Avastin
1.2.8 Herceptin
1.2.9 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biologic Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diabetes
1.3.3 Inflammation
1.3.4 Auto-Immune Diseases
1.3.5 Blood Diseases
1.3.6 Cardiovascular Diseases
1.3.7 Others
1.4 Global Biologic Drugs Market Size & Forecast
1.4.1 Global Biologic Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Biologic Drugs Sales in Volume (2017-2028)
1.4.3 Global Biologic Drugs Price (2017-2028)
1.5 Global Biologic Drugs Production Capacity Analysis
1.5.1 Global Biologic Drugs Total Production Capacity (2017-2028)
1.5.2 Global Biologic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biologic Drugs Market Drivers
1.6.2 Biologic Drugs Market Restraints
1.6.3 Biologic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biologic Drugs Product and Services
2.1.4 Roche Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Biologic Drugs Product and Services
2.2.4 Abbott Laboratories Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Biologic Drugs Product and Services
2.3.4 Johnson & Johnson Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck & Co.
2.4.1 Merck & Co. Details
2.4.2 Merck & Co. Major Business
2.4.3 Merck & Co. Biologic Drugs Product and Services
2.4.4 Merck & Co. Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Biologic Drugs Product and Services
2.5.4 Pfizer Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Biologic Drugs Product and Services
2.6.4 Amgen Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Biologic Drugs Product and Services
2.7.4 Sanofi Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Biologic Drugs Product and Services
2.8.4 Novartis Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Biologic Drugs Product and Services
2.9.4 Eli Lilly Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Biologic Drugs Product and Services
2.10.4 Amgen Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Biologic Drugs Breakdown Data by Manufacturer
3.1 Global Biologic Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Biologic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Biologic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Biologic Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Biologic Drugs Manufacturer Market Share in 2021
3.5 Global Biologic Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Biologic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biologic Drugs Market Size by Region
4.1.1 Global Biologic Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Biologic Drugs Revenue by Region (2017-2028)
4.2 North America Biologic Drugs Revenue (2017-2028)
4.3 Europe Biologic Drugs Revenue (2017-2028)
4.4 Asia-Pacific Biologic Drugs Revenue (2017-2028)
4.5 South America Biologic Drugs Revenue (2017-2028)
4.6 Middle East and Africa Biologic Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Biologic Drugs Sales in Volume by Type (2017-2028)
5.2 Global Biologic Drugs Revenue by Type (2017-2028)
5.3 Global Biologic Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Biologic Drugs Sales in Volume by Application (2017-2028)
6.2 Global Biologic Drugs Revenue by Application (2017-2028)
6.3 Global Biologic Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Biologic Drugs Sales by Type (2017-2028)
7.2 North America Biologic Drugs Sales by Application (2017-2028)
7.3 North America Biologic Drugs Market Size by Country
7.3.1 North America Biologic Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Biologic Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Biologic Drugs Sales by Type (2017-2028)
8.2 Europe Biologic Drugs Sales by Application (2017-2028)
8.3 Europe Biologic Drugs Market Size by Country
8.3.1 Europe Biologic Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Biologic Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Biologic Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Biologic Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Biologic Drugs Market Size by Region
9.3.1 Asia-Pacific Biologic Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Biologic Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Biologic Drugs Sales by Type (2017-2028)
10.2 South America Biologic Drugs Sales by Application (2017-2028)
10.3 South America Biologic Drugs Market Size by Country
10.3.1 South America Biologic Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Biologic Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biologic Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Biologic Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Biologic Drugs Market Size by Country
11.3.1 Middle East & Africa Biologic Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Biologic Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Biologic Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Biologic Drugs
12.3 Biologic Drugs Production Process
12.4 Biologic Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Biologic Drugs Typical Distributors
13.3 Biologic Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Biologic Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Biologic Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Biologic Drugs Product and Services
Table 6. Roche Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Major Business
Table 9. Abbott Laboratories Biologic Drugs Product and Services
Table 10. Abbott Laboratories Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Biologic Drugs Product and Services
Table 14. Johnson & Johnson Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 16. Merck & Co. Major Business
Table 17. Merck & Co. Biologic Drugs Product and Services
Table 18. Merck & Co. Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Biologic Drugs Product and Services
Table 22. Pfizer Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Amgen Basic Information, Manufacturing Base and Competitors
Table 24. Amgen Major Business
Table 25. Amgen Biologic Drugs Product and Services
Table 26. Amgen Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Biologic Drugs Product and Services
Table 30. Sanofi Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Biologic Drugs Product and Services
Table 34. Novartis Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Biologic Drugs Product and Services
Table 38. Eli Lilly Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Amgen Basic Information, Manufacturing Base and Competitors
Table 40. Amgen Major Business
Table 41. Amgen Biologic Drugs Product and Services
Table 42. Amgen Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Biologic Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Biologic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Biologic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Biologic Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Biologic Drugs Production Site of Key Manufacturer
Table 48. Biologic Drugs New Entrant and Capacity Expansion Plans
Table 49. Biologic Drugs Mergers & Acquisitions in the Past Five Years
Table 50. Global Biologic Drugs Sales by Region (2017-2022) & (K Units)
Table 51. Global Biologic Drugs Sales by Region (2023-2028) & (K Units)
Table 52. Global Biologic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Biologic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Global Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Global Biologic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Biologic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Biologic Drugs Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Biologic Drugs Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 61. Global Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Global Biologic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Biologic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Biologic Drugs Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Biologic Drugs Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Biologic Drugs Sales by Country (2017-2022) & (K Units)
Table 67. North America Biologic Drugs Sales by Country (2023-2028) & (K Units)
Table 68. North America Biologic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Biologic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 71. North America Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 72. North America Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 73. North America Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Europe Biologic Drugs Sales by Country (2017-2022) & (K Units)
Table 75. Europe Biologic Drugs Sales by Country (2023-2028) & (K Units)
Table 76. Europe Biologic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Biologic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Europe Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Europe Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Europe Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Biologic Drugs Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Biologic Drugs Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Biologic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Biologic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 90. South America Biologic Drugs Sales by Country (2017-2022) & (K Units)
Table 91. South America Biologic Drugs Sales by Country (2023-2028) & (K Units)
Table 92. South America Biologic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Biologic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 95. South America Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 96. South America Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 97. South America Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Biologic Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Biologic Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Biologic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Biologic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Biologic Drugs Raw Material
Table 107. Key Manufacturers of Biologic Drugs Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Biologic Drugs Typical Distributors
Table 111. Biologic Drugs Typical Customers
List of Figures
Figure 1. Biologic Drugs Picture
Figure 2. Global Biologic Drugs Revenue Market Share by Type in 2021
Figure 3. Humira
Figure 4. Remicade
Figure 5. Rituxan
Figure 6. Enbrel
Figure 7. Lantus
Figure 8. Avastin
Figure 9. Herceptin
Figure 10. Others
Figure 11. Global Biologic Drugs Revenue Market Share by Application in 2021
Figure 12. Diabetes
Figure 13. Inflammation
Figure 14. Auto-Immune Diseases
Figure 15. Blood Diseases
Figure 16. Cardiovascular Diseases
Figure 17. Others
Figure 18. Global Biologic Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 19. Global Biologic Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 20. Global Biologic Drugs Sales (2017-2028) & (K Units)
Figure 21. Global Biologic Drugs Price (2017-2028) & (USD/Unit)
Figure 22. Global Biologic Drugs Production Capacity (2017-2028) & (K Units)
Figure 23. Global Biologic Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 24. Biologic Drugs Market Drivers
Figure 25. Biologic Drugs Market Restraints
Figure 26. Biologic Drugs Market Trends
Figure 27. Global Biologic Drugs Sales Market Share by Manufacturer in 2021
Figure 28. Global Biologic Drugs Revenue Market Share by Manufacturer in 2021
Figure 29. Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 30. Top 3 Biologic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 31. Top 6 Biologic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 32. Global Biologic Drugs Sales Market Share by Region (2017-2028)
Figure 33. Global Biologic Drugs Revenue Market Share by Region (2017-2028)
Figure 34. North America Biologic Drugs Revenue (2017-2028) & (USD Million)
Figure 35. Europe Biologic Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Asia-Pacific Biologic Drugs Revenue (2017-2028) & (USD Million)
Figure 37. South America Biologic Drugs Revenue (2017-2028) & (USD Million)
Figure 38. Middle East & Africa Biologic Drugs Revenue (2017-2028) & (USD Million)
Figure 39. Global Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 40. Global Biologic Drugs Revenue Market Share by Type (2017-2028)
Figure 41. Global Biologic Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 42. Global Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 43. Global Biologic Drugs Revenue Market Share by Application (2017-2028)
Figure 44. Global Biologic Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 45. North America Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 46. North America Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 47. North America Biologic Drugs Sales Market Share by Country (2017-2028)
Figure 48. North America Biologic Drugs Revenue Market Share by Country (2017-2028)
Figure 49. United States Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 53. Europe Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 54. Europe Biologic Drugs Sales Market Share by Country (2017-2028)
Figure 55. Europe Biologic Drugs Revenue Market Share by Country (2017-2028)
Figure 56. Germany Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Biologic Drugs Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Biologic Drugs Sales Market Share by Region (2017-2028)
Figure 64. Asia-Pacific Biologic Drugs Revenue Market Share by Region (2017-2028)
Figure 65. China Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Korea Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 72. South America Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 73. South America Biologic Drugs Sales Market Share by Country (2017-2028)
Figure 74. South America Biologic Drugs Revenue Market Share by Country (2017-2028)
Figure 75. Brazil Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East & Africa Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 78. Middle East & Africa Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 79. Middle East & Africa Biologic Drugs Sales Market Share by Region (2017-2028)
Figure 80. Middle East & Africa Biologic Drugs Revenue Market Share by Region (2017-2028)
Figure 81. Turkey Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Egypt Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. South Africa Biologic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Manufacturing Cost Structure Analysis of Biologic Drugs in 2021
Figure 86. Manufacturing Process Analysis of Biologic Drugs
Figure 87. Biologic Drugs Industrial Chain
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
Figure 89. Methodology
Figure 90. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
